IGF-1 vs Growth Hormone

Growth hormone and IGF-1 are two closely linked players in the body's growth signalling system. Growth hormone is released by the pituitary gland; IGF-1 is a downstream messenger made largely in response to it. Understanding how an upstream signal differs from its steady downstream marker explains why the two are measured in different ways.

A pulsing signal versus a steady marker

The most useful frame for this comparison is the difference between a fluctuating signal and a steadier downstream marker. Growth hormone is released in bursts that rise and fall through the day and night, so a single measurement captures only a moment. IGF-1, produced in response to growth hormone, tends to be much more stable over the course of a day. So growth hormone is the pulsing instruction, and IGF-1 is the more even reflection of how strong that instruction has been over time.

What each one is

Growth hormone (GH, also called somatotropin) is a hormone made and released by the pituitary gland at the base of the brain. It acts on many tissues and influences growth, body composition, and aspects of metabolism. A defining feature is that it is secreted in pulses, with levels varying considerably depending on factors such as sleep, activity, and the time since eating. Because of this variability, a one-off blood level can be hard to interpret on its own.

IGF-1 (insulin-like growth factor 1) is a hormone produced largely by the liver and other tissues in response to growth hormone. It carries out many of growth hormone's effects on tissues and provides feedback into the system. Because IGF-1 changes more slowly than growth hormone, it acts as a more stable indicator of overall growth hormone activity, integrating the effect of those pulses over a longer window.

How the axis connects them

The clearest link is that growth hormone drives IGF-1 production. The pituitary releases growth hormone, which signals the liver and other tissues to make IGF-1, and IGF-1 in turn feeds back to help regulate the system. This connected loop is often called the GH–IGF-1 axis. Because IGF-1 sits one step downstream and changes gradually, it reflects the cumulative effect of growth hormone rather than any single pulse, which is the heart of why the two are measured and read differently.

How they differ

The central difference is position in the axis and stability over time. Growth hormone is the upstream signal that swings widely from hour to hour; IGF-1 is the downstream marker that stays comparatively steady. This shapes how each is tested. A random growth hormone level is often difficult to interpret because of the pulses, so it is sometimes assessed with timed or stimulation-based approaches. IGF-1, being steadier, can often be measured in a single sample, though it must always be read against age and sex, since typical levels change considerably across the lifespan.

Side-by-side comparison

The table below summarises typical differences. Any laboratory values referenced are illustrative only and vary by laboratory, age, sex, and the assay used.

When the distinction matters

The distinction matters because the two give different kinds of information. When the question is about overall growth hormone activity over time, IGF-1 is often the more practical starting point because it is stable and can be sampled without precise timing. When a closer look at the pituitary's secretion itself is needed, growth hormone may be assessed with timed sampling or stimulation approaches that account for its pulses. Reading the two together, in the context of age and sex, gives a fuller picture than either alone.

Symptoms linked to growth hormone activity do not reliably indicate which measurement is most informative, so interpretation depends on the testing strategy and the clinical context rather than on the way a person feels.

Common points of confusion

A frequent source of confusion is expecting a single growth hormone blood level to give a clear answer; because of the pulses, an isolated value is often hard to interpret. Another mix-up is treating IGF-1 and growth hormone as interchangeable, when one is the upstream signal and the other a downstream marker. People also sometimes compare an IGF-1 result against a generic range rather than an age-appropriate one, even though typical IGF-1 levels shift substantially across life. Keeping "pulsing signal versus steady marker" in mind resolves most of these.

How they relate

The simplest way to picture the relationship is as a chain of command: the pituitary sends out growth hormone in bursts, growth hormone tells the liver and other tissues to make IGF-1, and IGF-1 both carries out many of the effects and feeds back to steady the system. Because IGF-1 changes slowly, it serves as a more even readout of how active the growth hormone signal has been, while growth hormone itself reflects the moment-to-moment instruction. They are two views of the same axis seen at different points. For a related hormone comparison, see DHEA vs Testosterone. You can also explore the hormones and blood tests sections, and browse more comparisons.